CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

TB Notes Newsletter

Return to Main Menu - TB Notes 1, 2008

No. 1, 2008

Revision of Technical Instructions for Panel Physicians

The Division of Global Migration and Quarantine (DGMQ) has completed the revision of the Technical Instructions for panel physicians. Since 2005, DGMQ has been working with DTBE to review scientific literature on overseas pre-immigration medical screening and develop new algorithms. Input was also solicited from the U.S. tuberculosis community. The 2007 Technical Instructions for Tuberculosis Screening and Treatment (TB TIs) provide a modernized approach to TB screening overseas for U.S. immigration applicants. For the first time, mycobacterial cultures will be required for applicants suspected of having TB disease. Moreover, drug susceptibility testing (DST) on positive isolates and directly observed therapy (DOT) according to CDC / American Thoracic Society (ATS) / Infectious Diseases Society of America (IDSA) standards will be required for applicants with TB disease. It is expected that implementation of the 2007 TB TIs should help prevent importation of TB into the United States, improve U.S. domestic TB control, and increase TB infrastructure globally.

The 2007 TB TIs were first implemented in April 2007 for the screening of 14,000 Burmese refugees from Thailand who were to be resettled to the United States. The 2007 TB TIs have also been recently implemented for all applicants from Mexico and the Philippines. Global implementation will occur over the next several years, beginning in priority countries determined by immigration patterns, refugee resettlements, burden of TB, and U.S. domestic foreign-born TB case rates.

—Reported by Drew Posey, MD
Div of Global Migration and Quarantine

 

Last Updated: 07/01/2008
Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov